Adagio Medical Holdings, Inc.
Datakwaliteit: 100%
ADGM
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
€ 1,41
€ 0,00
(0,00%)
Marktkapitalisatie: 31,32 M
Prijs
€ 1,41
Marktkapitalisatie
31,32 M
Dagbereik
€ 1,38 — € 1,50
52-Weeksbereik
€ 0,74 — € 2,87
Volume
173.749
Openen € 1,38
50D / 200D Gem.
€ 1,05
34,58% above
50D / 200D Gem.
€ 1,25
12,65% above
Quick Summary
Belangrijkste Punten
Negative free cash flow of -19,39 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-682,19%
Onder sectorgemiddelde (-53,47%)
ROIC-65,46%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,84
Interest Coverage-7,53
Waardering
PE (TTM)
-1,25
Boven sectorgemiddelde (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,3 | -1,5 |
| P/B | — | 1,6 |
| ROE % | -682,2 | -53,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -25,08 M |
| ROE | -682,19% | ROA | -74,41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -19,39 M |
| ROIC | -65,46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,84 |
| Interest Coverage | -7,53 | Asset Turnover | 0,00 |
| Working Capital | -1,56 M | Tangible Book Value | -22,25 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,25 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -61,91% | ||
| Market Cap | 31,32 M | Enterprise Value | 47,83 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,51 | Revenue / Share | 0,00 |
| FCF / Share | -0,87 | OCF / Share | -0,86 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 77,29% |
| SBC-Adj. FCF | -19,98 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 0,0 | 269.000,0 |
| Net Income | -25,08 M | -53,76 M |
| EPS (Diluted) | -1,51 | -3,70 |
| Gross Profit | — | — |
| Operating Income | -21,89 M | -62,48 M |
| EBITDA | — | — |
| R&D Expenses | 10,64 M | 4,63 M |
| SG&A Expenses | 10,57 M | 6,98 M |
| D&A | 970.000,0 | 740.000,0 |
| Interest Expense | 2,91 M | 1,11 M |
| Income Tax | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 43,25 M | 48,45 M |
| Total Liabilities | 30,85 M | 28,54 M |
| Shareholders' Equity | 12,40 M | 19,91 M |
| Total Debt | 21,04 M | 16,08 M |
| Cash & Equivalents | 17,11 M | 20,59 M |
| Current Assets | 20,08 M | 25,35 M |
| Current Liabilities | 8,23 M | 7,76 M |
{"event":"ticker_viewed","properties":{"ticker":"ADGM","listing_kind":"stock","pathname":"/stocks/adgm","exchange":"Nasdaq","country":"US"}}